{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:16:26Z","timestamp":1790680586482,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T00:00:00Z","timestamp":1362182400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s13181-013-0294-y","type":"journal-article","created":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T06:06:11Z","timestamp":1362204371000},"page":"163-171","source":"Crossref","is-referenced-by-count":137,"title":["In the Zzz Zone: The Effects of Z-Drugs on Human Performance and Driving"],"prefix":"10.1007","volume":"9","author":[{"given":"Naren","family":"Gunja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,2]]},"reference":[{"key":"294_CR1","doi-asserted-by":"crossref","unstructured":"Gunja N (2013) The clinical & forensic toxicology of Z-drugs. J Med Toxicol. doi: 10.1007\/s13181-013-0292-0","DOI":"10.1007\/s13181-013-0292-0"},{"issue":"5","key":"294_CR2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1755-5949.2010.00158.x","volume":"17","author":"A Dang","year":"2011","unstructured":"Dang A, Garg A, Rataboli PV (2011) Role of zolpidem in the management of insomnia. CNS Neurosci Ther 17(5):387\u2013397","journal-title":"CNS Neurosci Ther"},{"issue":"6","key":"294_CR3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1053\/smrv.2000.0126","volume":"4","author":"J Wagner","year":"2000","unstructured":"Wagner J, Wagner ML (2000) Non-benzodiazepines for the treatment of insomnia. Sleep Med Rev 4(6):551\u2013581","journal-title":"Sleep Med Rev"},{"issue":"3","key":"294_CR4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MJT.0b013e31804c7292","volume":"14","author":"RL Barkin","year":"2007","unstructured":"Barkin RL (2007) Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms. Am J Ther 14(3):299\u2013305","journal-title":"Am J Ther"},{"issue":"4","key":"294_CR5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/00003088-200443040-00002","volume":"43","author":"DR Drover","year":"2004","unstructured":"Drover DR (2004) Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone. Clin Pharmacokinet 43(4):227\u2013238","journal-title":"Clin Pharmacokinet"},{"issue":"9293","key":"294_CR6","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(01)06656-9","volume":"358","author":"CF George","year":"2001","unstructured":"George CF (2001) Pyrazolopyrimidines. Lancet 358(9293):1623\u20131626","journal-title":"Lancet"},{"issue":"12","key":"294_CR7","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1177\/0091270006293303","volume":"46","author":"DJ Greenblatt","year":"2006","unstructured":"Greenblatt DJ, Legangneux E, Harmatz JS et al (2006) Dynamics and kinetics of a modified-release formulation of zolpidem: comparison with immediate-release standard zolpidem and placebo. J Clin Pharmacol 46(12):1469\u20131480","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"294_CR8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2146\/ajhp050357","volume":"63","author":"CJ Halas","year":"2006","unstructured":"Halas CJ (2006) Eszopiclone. Am J Health Syst Pharm 63(1):41\u201348","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"294_CR9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.clinthera.2006.04.014","volume":"28","author":"J Najib","year":"2006","unstructured":"Najib J (2006) Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia. Clin Ther 28(4):491\u2013516","journal-title":"Clin Ther"},{"issue":"11","key":"294_CR10","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1177\/0269881109106927","volume":"24","author":"DJ Nutt","year":"2010","unstructured":"Nutt DJ, Stahl SM (2010) Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics. J Psychopharmacol 24(11):1601\u20131612","journal-title":"J Psychopharmacol"},{"issue":"6","key":"294_CR11","first-page":"512","volume":"75","author":"MA Paul","year":"2004","unstructured":"Paul MA, Gray G, MacLellan M et al (2004) Sleep-inducing pharmaceuticals: a comparison of melatonin, zaleplon, zopiclone, and temazepam. Aviat Space Environ Med 75(6):512\u2013519","journal-title":"Aviat Space Environ Med"},{"key":"294_CR12","unstructured":"US Food and Drug Administration (2007) FDA requests label change for all sleep disorder drug products. http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/2007\/ucm108868.htm . Accessed 1 Dec 2012"},{"issue":"1","key":"294_CR13","first-page":"2","volume":"26","author":"Therapeutic Goods Administration","year":"2007","unstructured":"Therapeutic Goods Administration (2007) Zolpidem and bizarre sleep related effects. Aust Adverse Drug React Bull 26(1):2\u20133, http:\/\/www.tga.gov.au\/pdf\/aadrb-0702.pdf","journal-title":"Aust Adverse Drug React Bull"},{"issue":"4","key":"294_CR14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2869.2011.00919.x","volume":"20","author":"M Ben-Hamou","year":"2011","unstructured":"Ben-Hamou M, Marshall NS, Grunstein RR et al (2011) Spontaneous adverse event reports associated with zolpidem in Australia 2001\u20132008. J Sleep Res 20(4):559\u2013568","journal-title":"J Sleep Res"},{"issue":"12","key":"294_CR15","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2165\/0023210-200822120-00005","volume":"22","author":"CR Dolder","year":"2008","unstructured":"Dolder CR, Nelson MH (2008) Hypnosedative-induced complex behaviours: incidence, mechanisms and management. CNS Drugs 22(12):1021\u20131036","journal-title":"CNS Drugs"},{"issue":"20","key":"294_CR16","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1080\/15287390600631763","volume":"69","author":"MB Forrester","year":"2006","unstructured":"Forrester MB (2006) Comparison of zolpidem and zaleplon exposures in Texas, 1998\u20132004. J Toxicol Environ Health A 69(20):1883\u20131892","journal-title":"J Toxicol Environ Health A"},{"issue":"6","key":"294_CR17","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00004714-200212000-00007","volume":"22","author":"JC Verster","year":"2002","unstructured":"Verster JC, Volkerts ER, Schreuder AH et al (2002) Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance. J Clin Psychopharmacol 22(6):576\u2013583","journal-title":"J Clin Psychopharmacol"},{"issue":"S2","key":"294_CR18","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1002\/(SICI)1099-1077(1998110)13:2+<S98::AID-HUP54>3.0.CO;2-1","volume":"13","author":"A Vermeeren","year":"1998","unstructured":"Vermeeren A, Danjou PE, O\u2019Hanlon JF (1998) Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20\u00a0mg on memory and actual driving performance. Hum Psychopharmacol 13(S2):S98\u2013S107","journal-title":"Hum Psychopharmacol"},{"issue":"2","key":"294_CR19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/hup.282","volume":"16","author":"I Hindmarch","year":"2001","unstructured":"Hindmarch I, Patat A, Stanley N et al (2001) Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening. Hum Psychopharmacol 16(2):159\u2013167","journal-title":"Hum Psychopharmacol"},{"issue":"2","key":"294_CR20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.-5251.2001.01520.x","volume":"53","author":"BM Stone","year":"2002","unstructured":"Stone BM, Turner C, Mills SL et al (2002) Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon. Br J Clin Pharmacol 53(2):196\u2013202","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"294_CR21","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.5665\/SLEEP.1272","volume":"34","author":"MA Mets","year":"2011","unstructured":"Mets MA, de Vries JM, de Senerpont Domis LM et al (2011) Next-day effects of ramelteon (8\u00a0mg), zopiclone (7.5\u00a0mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects. Sleep 34(10):1327\u20131334","journal-title":"Sleep"},{"issue":"1","key":"294_CR22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.sleep.2004.09.001","volume":"6","author":"R Rosenberg","year":"2005","unstructured":"Rosenberg R, Caron J, Roth T et al (2005) An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults. Sleep Med 6(1):15\u201322","journal-title":"Sleep Med"},{"issue":"12","key":"294_CR23","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1185\/174234304X15174","volume":"20","author":"GK Zammit","year":"2004","unstructured":"Zammit GK, McNabb LJ, Caron J et al (2004) Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia. Curr Med Res Opin 20(12):1979\u20131991","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"294_CR24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hup.936","volume":"23","author":"J Boyle","year":"2008","unstructured":"Boyle J, Trick L, Johnsen S et al (2008) Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone. Hum Psychopharmacol 23(5):385\u2013397","journal-title":"Hum Psychopharmacol"},{"issue":"5","key":"294_CR25","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/JCP.0b013e3182664eec","volume":"32","author":"J Boyle","year":"2012","unstructured":"Boyle J, Groeger JA, Paska W et al (2012) A method to assess the dissipation of residual hypnotics: eszopiclone versus zopiclone. J Clin Psychopharmacol 32(5):704\u2013709","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"294_CR26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1081\/ADA-120020513","volume":"29","author":"WW Stoops","year":"2003","unstructured":"Stoops WW, Rush CR (2003) Differential effects in humans after repeated administrations of zolpidem and triazolam. Am J Drug Alcohol Abuse 29(2):281\u2013299","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"294_CR27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1037\/a0025237","volume":"20","author":"BA Kleykamp","year":"2012","unstructured":"Kleykamp BA, Griffiths RR, McCann UD et al (2012) Acute effects of zolpidem extended-release on cognitive performance and sleep in healthy males after repeated nightly use. Exp Clin Psychopharmacol 20(1):28\u201339","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"294_CR28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1532-5415.2010.03229.x","volume":"59","author":"DJ Frey","year":"2011","unstructured":"Frey DJ, Ortega JD, Wiseman C et al (2011) Influence of zolpidem and sleep inertia on balance and cognition during nighttime awakening: a randomized placebo-controlled trial. J Am Geriatr Soc 59(1):73\u201381","journal-title":"J Am Geriatr Soc"},{"issue":"1 Pt 2","key":"294_CR29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2869.2009.00757.x","volume":"19","author":"PT Morgan","year":"2010","unstructured":"Morgan PT, Kehne JH, Sprenger KJ et al (2010) Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans. J Sleep Res 19(1 Pt 2):157\u2013164","journal-title":"J Sleep Res"},{"key":"294_CR30","doi-asserted-by":"crossref","unstructured":"Zanin KA, Patti CL, Sanday L et al (2012) Effects of zolpidem on sedation, anxiety, and memory in the plus-maze discriminative avoidance task. Psychopharmacology (Berl). doi: 10.1007\/s00213-012-2756-3","DOI":"10.1007\/s00213-012-2756-3"},{"issue":"6","key":"294_CR31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.18773\/austprescr.2008.084","volume":"31","author":"LG Olson","year":"2008","unstructured":"Olson LG (2008) Hypnotic hazards: adverse effects of zolpidem and other z-drugs. Aust Prescr 31(6):146\u2013149","journal-title":"Aust Prescr"},{"issue":"2","key":"294_CR32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/15563650600956741","volume":"45","author":"MJ Tsai","year":"2007","unstructured":"Tsai MJ, Tsai YH, Huang YB (2007) Compulsive activity and anterograde amnesia after zolpidem use. Clin Toxicol (Phila) 45(2):179\u2013181","journal-title":"Clin Toxicol (Phila)"},{"issue":"1","key":"294_CR33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.euroneuro.2008.08.007","volume":"19","author":"JH Tsai","year":"2009","unstructured":"Tsai JH, Yang P, Chen CC et al (2009) Zolpidem-induced amnesia and somnambulism: rare occurrences? Eur Neuropsychopharmacol 19(1):74\u201376","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"294_CR34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.smrv.2010.12.004","volume":"15","author":"MR Pressman","year":"2011","unstructured":"Pressman MR (2011) Sleep driving: sleepwalking variant or misuse of z-drugs? Sleep Med Rev 15(5):285\u2013292","journal-title":"Sleep Med Rev"},{"issue":"6","key":"294_CR35","doi-asserted-by":"crossref","first-page":"486","DOI":"10.7326\/0003-4819-148-6-200803180-00026","volume":"148","author":"MR Southworth","year":"2008","unstructured":"Southworth MR, Kortepeter C, Hughes A (2008) Nonbenzodiazepine hypnotic use and cases of \u201csleep driving\u201d. Ann Intern Med 148(6):486\u2013487","journal-title":"Ann Intern Med"},{"issue":"11","key":"294_CR36","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.amjmed.2008.04.035","volume":"121","author":"JA Doane","year":"2008","unstructured":"Doane JA, Dalpiaz AS (2008) Zolpidem-induced sleep-driving. Am J Med 121(11):e5","journal-title":"Am J Med"},{"issue":"5","key":"294_CR37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5664\/jcsm.27605","volume":"5","author":"R Hoque","year":"2009","unstructured":"Hoque R, Chesson AL Jr (2009) Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem. J Clin Sleep Med 5(5):471\u2013476","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"294_CR38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jsmc.2011.08.003","volume":"6","author":"MR Pressman","year":"2011","unstructured":"Pressman MR (2011) Sleep and drug-impaired driving overlap syndrome. Sleep Medicine Clin 6(4):441\u2013445","journal-title":"Sleep Medicine Clin"},{"issue":"7526","key":"294_CR39","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","volume":"331","author":"J Glass","year":"2005","unstructured":"Glass J, Lanctot KL, Herrmann N et al (2005) Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 331(7526):1169","journal-title":"BMJ"},{"issue":"21","key":"294_CR40","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","volume":"169","author":"JC Woolcott","year":"2009","unstructured":"Woolcott JC, Richardson KJ, Wiens MO et al (2009) Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169(21):1952\u20131960","journal-title":"Arch Intern Med"},{"issue":"5","key":"294_CR41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00023210-200418050-00003","volume":"18","author":"A Vermeeren","year":"2004","unstructured":"Vermeeren A (2004) Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 18(5):297\u2013328","journal-title":"CNS Drugs"},{"issue":"11","key":"294_CR42","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2165\/00002512-200320110-00004","volume":"20","author":"MJ Panneman","year":"2003","unstructured":"Panneman MJ, Goettsch WG, Kramarz P et al (2003) The costs of benzodiazepine-associated hospital-treated fall injuries in the EU: a Pharmo study. Drugs Aging 20(11):833\u2013839","journal-title":"Drugs Aging"},{"issue":"4","key":"294_CR43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3961\/jpmph.2012.45.4.219","volume":"45","author":"DY Kang","year":"2012","unstructured":"Kang DY, Park S, Rhee CW et al (2012) Zolpidem use and risk of fracture in elderly insomnia patients. J Prev Med Public Health 45(4):219\u2013226","journal-title":"J Prev Med Public Health"},{"issue":"12","key":"294_CR44","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/j.1532-5415.2001.49280.x","volume":"49","author":"PS Wang","year":"2001","unstructured":"Wang PS, Bohn RL, Glynn RJ et al (2001) Zolpidem use and hip fractures in older people. J Am Geriatr Soc 49(12):1685\u20131690","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"294_CR45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.smrv.2009.10.008","volume":"14","author":"MA Mets","year":"2010","unstructured":"Mets MA, Volkerts ER, Olivier B et al (2010) Effect of hypnotic drugs on body balance and standing steadiness. Sleep Med Rev 14(4):259\u2013267","journal-title":"Sleep Med Rev"},{"issue":"4","key":"294_CR46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/157340007782408860","volume":"3","author":"JC Verster","year":"2007","unstructured":"Verster JC, Volkerts ER, Spence DW et al (2007) Effects of sleep medications on cognition, psychomotor skills, memory and driving performance in the elderly. Curr Psychiatry Rev 3(4):281\u2013292","journal-title":"Curr Psychiatry Rev"},{"issue":"5","key":"294_CR47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/hup.310","volume":"16","author":"A Patat","year":"2001","unstructured":"Patat A, Paty I, Hindmarch I (2001) Pharmacodynamic profile of zaleplon, a new non-benzodiazepine hypnotic agent. Hum Psychopharmacol 16(5):369\u2013392","journal-title":"Hum Psychopharmacol"},{"issue":"3","key":"294_CR48","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00004714-200006000-00007","volume":"20","author":"SM Troy","year":"2000","unstructured":"Troy SM, Lucki I, Unruh MA et al (2000) Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance. J Clin Psychopharmacol 20(3):328\u2013337","journal-title":"J Clin Psychopharmacol"},{"issue":"12","key":"294_CR49","first-page":"1263","volume":"74","author":"MA Paul","year":"2003","unstructured":"Paul MA, Gray G, Kenny G et al (2003) Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance. Aviat Space Environ Med 74(12):1263\u20131270","journal-title":"Aviat Space Environ Med"},{"issue":"1","key":"294_CR50","first-page":"10","volume":"78","author":"WF Storm","year":"2007","unstructured":"Storm WF, Eddy DR, Welch CB et al (2007) Cognitive performance following premature awakening from zolpidem or melatonin induced daytime sleep. Aviat Space Environ Med 78(1):10\u201320","journal-title":"Aviat Space Environ Med"},{"issue":"1","key":"294_CR51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.aap.2008.10.011","volume":"41","author":"KK Ojaniemi","year":"2009","unstructured":"Ojaniemi KK, Lintonen TP, Impinen AO et al (2009) Trends in driving under the influence of drugs: a register-based study of DUID suspects during 1977\u20132007. Accid Anal Prev 41(1):191\u2013196","journal-title":"Accid Anal Prev"},{"issue":"4","key":"294_CR52","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1742-6723.2007.00958.x","volume":"19","author":"CW Ch\u2019ng","year":"2007","unstructured":"Ch\u2019ng CW, Fitzgerald M, Gerostamoulos J et al (2007) Drug use in motor vehicle drivers presenting to an Australian, adult major trauma centre. Emerg Med Australas 19(4):359\u2013365","journal-title":"Emerg Med Australas"},{"issue":"1","key":"294_CR53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/jama.1997.03550010041037","volume":"278","author":"B Hemmelgarn","year":"1997","unstructured":"Hemmelgarn B, Suissa S, Huang A et al (1997) Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 278(1):27\u201331","journal-title":"JAMA"},{"issue":"3","key":"294_CR54","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/15389588.2012.654411","volume":"13","author":"E Vingilis","year":"2012","unstructured":"Vingilis E, Wilk P (2012) Medical conditions, medication use, and their relationship with subsequent motor vehicle injuries: examination of the Canadian National Population Health Survey. Traffic Inj Prev 13(3):327\u2013336","journal-title":"Traffic Inj Prev"},{"issue":"9137","key":"294_CR55","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(98)04087-2","volume":"352","author":"F Barbone","year":"1998","unstructured":"Barbone F, McMahon AD, Davey PG et al (1998) Association of road-traffic accidents with benzodiazepine use. Lancet 352(9137):1331\u20131336","journal-title":"Lancet"},{"issue":"8","key":"294_CR56","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.sleep.2007.11.011","volume":"9","author":"I Gustavsen","year":"2008","unstructured":"Gustavsen I, Bramness JG, Skurtveit S et al (2008) Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 9(8):818\u2013822","journal-title":"Sleep Med"},{"issue":"5","key":"294_CR57","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.aap.2008.06.015","volume":"40","author":"H Gjerde","year":"2008","unstructured":"Gjerde H, Normann PT, Pettersen BS et al (2008) Prevalence of alcohol and drugs among Norwegian motor vehicle drivers: a roadside survey. Accid Anal Prev 40(5):1765\u20131772","journal-title":"Accid Anal Prev"},{"issue":"1\u20133","key":"294_CR58","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.forsciint.2011.05.021","volume":"212","author":"H Gjerde","year":"2011","unstructured":"Gjerde H, Christophersen AS, Normann PT et al (2011) Toxicological investigations of drivers killed in road traffic accidents in Norway during 2006\u20132008. Forensic Sci Int 212(1\u20133):102\u2013109","journal-title":"Forensic Sci Int"},{"issue":"4","key":"294_CR59","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/clpt.2011.3","volume":"89","author":"L Orriols","year":"2011","unstructured":"Orriols L, Philip P, Moore N et al (2011) Benzodiazepine-like hypnotics and the associated risk of road traffic accidents. Clin Pharmacol Ther 89(4):595\u2013601","journal-title":"Clin Pharmacol Ther"},{"key":"294_CR60","doi-asserted-by":"crossref","unstructured":"Elvik R (2012) Risk of road accident associated with the use of drugs: a systematic review and meta-analysis of evidence from epidemiological studies. Accid Anal Prev. doi: 10.1016\/j.aap.2012.06.017","DOI":"10.1016\/j.aap.2012.06.017"},{"issue":"3","key":"294_CR61","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/15389588.2011.652751","volume":"13","author":"JC Verster","year":"2012","unstructured":"Verster JC, Roth T (2012) Gender differences in highway driving performance after administration of sleep medication: a review of the literature. Traffic Inj Prev 13(3):286\u2013292","journal-title":"Traffic Inj Prev"},{"issue":"S2","key":"294_CR62","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1002\/(SICI)1099-1077(1998110)13:2+<S49::AID-HUP49>3.0.CO;2-1","volume":"13","author":"WJ Riedel","year":"1998","unstructured":"Riedel WJ, Vermeeren A, Van Boxtel MPJ et al (1998) Mechanisms of drug-induced driving impairment: a dimensional approach. Hum Psychopharmacol Clin Exp 13(S2):S49\u2013S63","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"4","key":"294_CR63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.smrv.2004.02.001","volume":"8","author":"JC Verster","year":"2004","unstructured":"Verster JC, Veldhuijzen DS, Volkerts ER (2004) Residual effects of sleep medication on driving ability. Sleep Med Rev 8(4):309\u2013325","journal-title":"Sleep Med Rev"},{"issue":"1","key":"294_CR64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/157488606775252674","volume":"1","author":"JC Verster","year":"2006","unstructured":"Verster JC, Veldhuijzen DS, Patat A et al (2006) Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test. Curr Drug Saf 1(1):63\u201371","journal-title":"Curr Drug Saf"},{"issue":"4","key":"294_CR65","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2869.2009.00746.x","volume":"18","author":"TR Leufkens","year":"2009","unstructured":"Leufkens TR, Lund JS, Vermeeren A (2009) Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem. J Sleep Res 18(4):387\u2013396","journal-title":"J Sleep Res"},{"issue":"4","key":"294_CR66","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/157488611798280933","volume":"6","author":"JC Verster","year":"2011","unstructured":"Verster JC, Spence DW, Shahid A et al (2011) Zopiclone as positive control in studies examining the residual effects of hypnotic drugs on driving ability. Curr Drug Saf 6(4):209\u2013218","journal-title":"Curr Drug Saf"},{"issue":"2","key":"294_CR67","first-page":"224","volume":"25","author":"A Vermeeren","year":"2002","unstructured":"Vermeeren A, Riedel WJ, van Boxtel MP et al (2002) Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. Sleep 25(2):224\u2013231","journal-title":"Sleep"},{"issue":"6","key":"294_CR68","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.sleep.2003.06.005","volume":"4","author":"M Partinen","year":"2003","unstructured":"Partinen M, Hirvonen K, Hublin C et al (2003) Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia. Sleep Med 4(6):553\u2013561","journal-title":"Sleep Med"},{"issue":"3","key":"294_CR69","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00213-010-2075-5","volume":"214","author":"ML Bocca","year":"2011","unstructured":"Bocca ML, Marie S, Lelong-Boulouard V et al (2011) Zolpidem and zopiclone impair similarly monotonous driving performance after a single nighttime intake in aged subjects. Psychopharmacology (Berl) 214(3):699\u2013706","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"294_CR70","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00213-009-1677-2","volume":"207","author":"M Meskali","year":"2009","unstructured":"Meskali M, Berthelon C, Marie S et al (2009) Residual effects of hypnotic drugs in aging drivers submitted to simulated accident scenarios: an exploratory study. Psychopharmacology 207(3):461\u2013467","journal-title":"Psychopharmacology"},{"issue":"1\u20133","key":"294_CR71","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.forsciint.2011.03.021","volume":"210","author":"H Gjerde","year":"2011","unstructured":"Gjerde H, Normann PT, Christophersen AS et al (2011) Prevalence of driving with blood drug concentrations above proposed new legal limits in Norway: estimations based on drug concentrations in oral fluid. Forensic Sci Int 210(1\u20133):221\u2013227","journal-title":"Forensic Sci Int"},{"issue":"1\u20133","key":"294_CR72","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.forsciint.2011.05.012","volume":"215","author":"M Chu","year":"2012","unstructured":"Chu M, Gerostamoulos D, Beyer J et al (2012) The incidence of drugs of impairment in oral fluid from random roadside testing. Forensic Sci Int 215(1\u20133):28\u201331","journal-title":"Forensic Sci Int"},{"issue":"1\u20133","key":"294_CR73","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.forsciint.2012.01.001","volume":"219","author":"V Vindenes","year":"2012","unstructured":"Vindenes V, Lund HME, Andresen W et al (2012) Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers. Forensic Sci Int 219(1\u20133):165\u2013171","journal-title":"Forensic Sci Int"},{"issue":"1\u20133","key":"294_CR74","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.forsciint.2012.05.008","volume":"222","author":"AW Jones","year":"2012","unstructured":"Jones AW, Holmgren A (2012) Concentrations of zolpidem and zopiclone in venous blood samples from impaired drivers compared with femoral blood from forensic autopsies. Forensic Sci Int 222(1\u20133):118\u2013123","journal-title":"Forensic Sci Int"},{"issue":"3","key":"294_CR75","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.aap.2009.01.011","volume":"41","author":"I Gustavsen","year":"2009","unstructured":"Gustavsen I, Al-Sammurraie M, Morland J et al (2009) Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers. Accid Anal Prev 41(3):462\u2013466","journal-title":"Accid Anal Prev"},{"issue":"3","key":"294_CR76","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jsr.2005.07.006","volume":"37","author":"JC Fell","year":"2006","unstructured":"Fell JC, Voas RB (2006) The effectiveness of reducing illegal blood alcohol concentration (BAC) limits for driving: evidence for lowering the limit to.05 BAC. J Safety Res 37(3):233\u2013243","journal-title":"J Safety Res"},{"key":"294_CR77","doi-asserted-by":"crossref","unstructured":"Verster JC, Roth T (2012) Blood drug concentrations of benzodiazepines correlate poorly with actual driving impairment. Sleep Med Rev. doi: 10.1016\/j.smrv.2012.05.004","DOI":"10.1016\/j.smrv.2012.05.004"},{"key":"294_CR78","unstructured":"Norwegian Institute of Public Health (2012) New legal limits in traffic for drugs other than alcohol. http:\/\/www.fhi.no\/eway\/default.aspx?pid=238&trg=MainLeft_5895&MainArea_5811=5895:0:15,5123:1:0:0:::0:0&MainLeft_5895=5825:95784::1:5896:1:::0:0 . Accessed 30 Jan 2013"},{"issue":"1\u20133","key":"294_CR79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2011.11.004","volume":"219","author":"V Vindenes","year":"2012","unstructured":"Vindenes V, Jordbru D, Knapskog AB et al (2012) Impairment based legislative limits for driving under the influence of non-alcohol drugs in Norway. Forensic Sci Int 219(1\u20133):1\u201311","journal-title":"Forensic Sci Int"},{"issue":"12","key":"294_CR80","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0149-2918(00)83043-X","volume":"22","author":"D Drover","year":"2000","unstructured":"Drover D, Lemmens H, Naidu S et al (2000) Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic\/pharmacodynamic profiles of zaleplon and zolpidem. Clin Ther 22(12):1443\u20131461","journal-title":"Clin Ther"},{"issue":"5","key":"294_CR81","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jat\/bks037","volume":"36","author":"GM Reisfield","year":"2012","unstructured":"Reisfield GM, Goldberger BA, Gold MS et al (2012) The mirage of impairing drug concentration thresholds: a rationale for zero tolerance per se driving under the influence of drugs laws. J Anal Toxicol 36(5):353\u2013356","journal-title":"J Anal Toxicol"},{"key":"294_CR82","unstructured":"The International Council on Alcohol, Drugs and Traffic Safety (ICADTS) (2007) Categorization system for medicinal drugs affecting driving performance. http:\/\/www.icadts.org\/reports\/medicinaldrugs1.pdf . Accessed 2 Dec 2012"},{"key":"294_CR83","unstructured":"The International Council on Alcohol, Drugs and Traffic Safety (2007) ICADTS drugs list. http:\/\/www.icadts.org\/reports\/medicinaldrugs2.pdf . Accessed on 2 Dec 2012"},{"issue":"3","key":"294_CR84","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3390\/ijerph6031041","volume":"6","author":"JC Verster","year":"2009","unstructured":"Verster JC, Mets MAJ (2009) Psychoactive medication and traffic safety. Int J Environ Res Public Health 6(3):1041\u20131054","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"294_CR85","doi-asserted-by":"crossref","first-page":"632","DOI":"10.5664\/jcsm.1468","volume":"7","author":"JS Poceta","year":"2011","unstructured":"Poceta JS (2011) Zolpidem ingestion, automatisms, and sleep driving: a clinical and legal case series. J Clin Sleep Med 7(6):632\u2013638","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"294_CR86","first-page":"535","volume":"39","author":"C Daley","year":"2011","unstructured":"Daley C, McNiel DE, Binder RL (2011) \u201cI did what?\u201d Zolpidem and the courts. J Am Acad Psychiatry Law 39(4):535\u2013542","journal-title":"J Am Acad Psychiatry Law"},{"issue":"1","key":"294_CR87","first-page":"5","volume":"31","author":"KJ Weiss","year":"2010","unstructured":"Weiss KJ, Del Busto E (2010) Sleep-driving and pathological intoxication: saved by the FDA? Am J Forensic Psychiatry 31(1):5\u201315","journal-title":"Am J Forensic Psychiatry"},{"issue":"2","key":"294_CR88","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/009318531103900205","volume":"39","author":"KJ Weiss","year":"2011","unstructured":"Weiss KJ, Watson C, Markov D et al (2011) Parasomnias, violence and the law. J Psychiatry Law 39(2):249\u2013286","journal-title":"J Psychiatry Law"},{"issue":"1","key":"294_CR89","first-page":"149","volume":"46","author":"M Horn","year":"2004","unstructured":"Horn M (2004) A rude awakening: what to do with the sleepwalking defense? BCL Rev 46(1):149\u2013182","journal-title":"BCL Rev"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-013-0294-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-013-0294-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-013-0294-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T03:21:39Z","timestamp":1595474499000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-013-0294-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,2]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["294"],"URL":"https:\/\/doi.org\/10.1007\/s13181-013-0294-y","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,2]]}}}